ETRA logo

Electra Therapeutics Inc.

ETRA
Healthcare|Medical - Pharmaceuticals|US
$7.80
+0.45 (+6.12%)

About

Electra Therapeutics, Inc. is a clinical stage biotechnology company. It is engaged in therapies against novel targets for diseases in immunology and cancer. The company was founded by Adam Rosenthal on October 11, 2018 and is headquartered in South San Francisco, CA.

Stock Price

-41.1%(1Y)
1M
-14.7%
3M
-41.1%
6M
-41.1%
YTD
-41.1%
1Y
-41.1%
3Y
-41.1%
5Y
-41.1%

Pipeline Summary

3 total trials
2
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
Recruiting: 2Completed: 1

Active Trials (2)

A Study of ELA026 in Participants With Relapsed/Refractory (R/R) T/NK Cell Malignancies (TCMs)
NCT07465835T Cell Malignancies
Phase 1Recruiting
Enrollment: 84 participants
Open-label Study of ELA026 in Participants With Secondary Hemophagocytic Lymphohistiocytosis (sHLH)
NCT05416307Secondary Hemophagocytic Lymphohistiocytosis (sHLH)
Phase 2Phase 3Recruiting
Enrollment: 156 participants

Key Facts

Market Cap$165.5M
Employees46
CEOQuehuong Dong
IPO DateSep 18, 2026
Beta0.00
52-Week Range$6.87 – $15.5
Avg Volume608,825
ExchangeNASDAQ

Ownership

Shares Outstanding21.2M

Recent Insider Trades

GORDON CARL LBUY
Nov 5, 202630,891 shares @ $7.31
GORDON CARL LBUY
Nov 4, 20265,000 shares @ $7.07
GORDON CARL LBUY
Nov 4, 20269,267 shares @ $7.78
GORDON CARL LBUY
Nov 3, 202624,400 shares @ $7.88
GORDON CARL LBUY
Nov 3, 202624,313 shares @ $7.84
Data last updated: Nov 9, 2026, 04:09 AM